Use of a VEGF antagonist to treat angiogenic eye disorders | Patent Publication Number 20160101152

US 20160101152 A1

Patent NumberUS 09669069 B2

Application Number14972560

Filled DateDec 17, 2015

Priority DateJan 13, 2011

Publication DateApr 14, 2016

Original AssigneeRegeneron Pharmaceuticals

Current AssigneeRegeneron Pharmaceuticals

Inventor/ApplicantsGeorge D. Yancopoulos

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.